MMP1 and neoplasm: Tissue Factor Pathway Inhibitor 2 (TFPI‐2), a Kunitz‐type serine protease inhibitor, impedes the invasion and metastasis ability of tumour cells via inhibiting the activities of Matrix Metallopeptidase 1 (MMP1), Matrix Metallopeptidase 3 (MMP3), plasmin and trypsin.181, 182